Stability of coagulation factors in thawed, solvent/detergent‐treated plasma during storage at 4 °C for 6 days
- 1 October 2004
- journal article
- Published by Wiley in Vox Sanguinis
- Vol. 87 (3) , 182-186
- https://doi.org/10.1111/j.1423-0410.2004.00552.x
Abstract
Background and Objectives Transfusion of fresh-frozen plasma is still a pillar in emergency medicine for using to prevent dilutional coagulopathy or disseminated intravascular coagulation after severe blood loss, but thawing procedures can delay its availability. On the other hand, the wastage of plasma, once thawed and not transfused within a defined time-period, represents an inefficient handling of economic resources and is contradictory to blood donor intentions. In this study we investigated the stability of coagulation factor activities and plasma protein levels during 6 days of storage of thawed solvent/detergent (S/D)-treated plasma at +4 °C. Our results may form the basis for reconsideration of expiry times of thawed S/D-treated plasma. Materials and Methods Five units of S/D-treated plasma (Octaplas®) were thawed and warmed to 20 °C, then recooled and stored at +4 °C for 6 days. The activities of coagulation factors II, V, VII, VIII, IX, X, XI and XII, fibrinogen, antithrombin (AT), protein C, protein S and von Willebrand factor antigen (vWF:Ag) were measured on days 0, 1, 2, 3 and 6. Results Except for protein S, the activities of all coagulation factors and inhibitors were at least 0·5 U/ml during storage at 4 °C for 6 days. The mean levels, during storage, of factors IX, X, XI and XII, vWF:Ag, fibrinogen and protein C were at least 94%, and of factors II, V and VIII, and AT at least 78%, of the levels immediately after thawing; the activity of factor VII decreased to 83% and of protein S to 43% of the baseline values. Conclusions Thawed S/D-treated plasma stored at +4 °C for up to 6 days still contains sufficient coagulation activities and plasma proteins to be regarded as suitable for transfusion in the established indications.Keywords
This publication has 12 references indexed in Scilit:
- Coagulant stability and sterility of thawed S/D‐treated plasmaTransfusion, 2002
- Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998Transfusion, 2002
- Manufacture and composition of fresh frozen plasma and virus-inactivated therapeutic plasma preparations: correlation between composition and therapeutic efficacyThrombosis Research, 2002
- Massive Blood ReplacementVox Sanguinis, 1999
- Replacement of Massive Blood LossVox Sanguinis, 1998
- In Vitro Characterization of Solvent/Detergent‐Treated Human Plasma and of Quarantine Fresh Frozen PlasmaVox Sanguinis, 1998
- SD Plasma in TTP and Coagulation Factor Deficiencies for which no Concentrates are AvailableVox Sanguinis, 1998
- Modulation of fibrinogen content in cryoprecipitate by temperature manipulation during plasma processingTransfusion, 1992
- Control of Large‐Scale Plasma Thawing for Recovery of Cryoprecipitate Factor VIII1Vox Sanguinis, 1982
- The Plasma Concentration of Factor VIII in the Normal PopulationBritish Journal of Haematology, 1964